3SBio, Inc. (TRSBF)
1.82
0.00 (0.00%)
USD |
OTCM |
Nov 18, 16:00
3SBio Price : 1.82 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 1.82 | 1.82 | 1.82 | 1.82 | 0.000 |
| Nov 17, 2026 | 1.82 | 1.82 | 1.82 | 1.82 | 0.000 |
| Nov 16, 2026 | 1.82 | 1.82 | 1.82 | 1.82 | 1000.00 |
| Nov 13, 2026 | 1.72 | 1.72 | 1.72 | 1.72 | 0.000 |
| Nov 12, 2026 | 1.72 | 1.72 | 1.72 | 1.72 | 171000.0 |
| Nov 11, 2026 | 1.72 | 1.72 | 1.72 | 1.72 | 0.000 |
| Nov 10, 2026 | 1.72 | 1.72 | 1.72 | 1.72 | 0.000 |
| Nov 09, 2026 | 1.72 | 1.72 | 1.72 | 1.72 | 0.000 |
| Nov 06, 2026 | 1.72 | 1.72 | 1.72 | 1.72 | 0.000 |
| Nov 05, 2026 | 1.72 | 1.72 | 1.72 | 1.72 | 0.000 |
| Nov 04, 2026 | 1.72 | 1.72 | 1.72 | 1.72 | 0.000 |
| Nov 03, 2026 | 1.72 | 1.72 | 1.72 | 1.72 | 0.000 |
| Nov 02, 2026 | 1.72 | 1.72 | 1.72 | 1.72 | 0.000 |
| Oct 30, 2026 | 1.72 | 1.72 | 1.72 | 1.72 | 25500.00 |
| Oct 29, 2026 | 1.725 | 1.725 | 1.725 | 1.725 | 0.000 |
| Oct 28, 2026 | 1.725 | 1.725 | 1.725 | 1.725 | 0.000 |
| Oct 27, 2026 | 1.725 | 1.725 | 1.725 | 1.725 | 0.000 |
| Oct 26, 2026 | 1.725 | 1.725 | 1.725 | 1.725 | 0.000 |
| Oct 23, 2026 | 1.725 | 1.725 | 1.725 | 1.725 | 0.000 |
| Oct 22, 2026 | 1.725 | 1.725 | 1.725 | 1.725 | 0.000 |
| Oct 21, 2026 | 1.725 | 1.725 | 1.725 | 1.725 | 0.000 |
| Oct 20, 2026 | 1.725 | 1.725 | 1.725 | 1.725 | 500.00 |
| Oct 19, 2026 | 1.90 | 1.90 | 1.90 | 1.90 | 0.000 |
| Oct 16, 2026 | 1.90 | 1.90 | 1.90 | 1.90 | 0.000 |
| Oct 15, 2026 | 1.90 | 1.90 | 1.90 | 1.90 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascletis Pharma, Inc. | 0.625 |
| CStone Pharmaceuticals Co. Ltd. | 0.75 |
| RemeGen Co., Ltd. | 9.96 |
| InnoCare Pharma Ltd. | 1.60 |
| Adagene, Inc. | 1.91 |
Price Related Metrics
| PE Ratio | 3.886 |
| PS Ratio | 1.819 |
| PEG Ratio | 0.0098 |
| Price to Book Value | 29.36 |
| Price to Free Cash Flow | 3.576 |
| Earnings Yield | 25.73% |
| Market Cap | 4.552B |
| PEGY Ratio | 0.0098 |
| Operating PE Ratio | 3.00 |
| Normalized PE Ratio | 3.926 |